These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1162990)

  • 41. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 42. Vaginal cytology in normal nonpregnant women, in pregnancy and in threatened abortion.
    Rameshkumar K; Thomas JA; Narayanan R
    Indian J Pathol Microbiol; 1987 Apr; 30(2):189-95. PubMed ID: 3273589
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic value of indomethacin in threatened abortion.
    Souka AR; Osman M; Sibaie F; Einen MA
    Prostaglandins; 1980 Mar; 19(3):457-60. PubMed ID: 6992229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative studies of the human chorionic gonadotropin levels in threatened abortion by the passive hemagglutination inhibition and Gravindex tests in the 1st and 2d trimesters of pregnancy].
    Berliński B; Wesołowski E; Berliński T
    Wiad Lek; 1980 Dec; 33(23):1887-9. PubMed ID: 7245748
    [No Abstract]   [Full Text] [Related]  

  • 45. [The prognostic value of ultrasonic scanning and serum estradiol in threatened abortion].
    Sederberg-Olsen SJ; Mathiesen HH; Olsen CE
    Ugeskr Laeger; 1984 Jun; 146(25):1853-5. PubMed ID: 6390893
    [No Abstract]   [Full Text] [Related]  

  • 46. [Epsilon-aminocaproic acid in the treatment of abortion].
    Klimek R; Stanek J
    Ginekol Pol; 1975 Jul; 46(7):747-50. PubMed ID: 1150103
    [No Abstract]   [Full Text] [Related]  

  • 47. [Role of progesterone in the 1st trimester of pregnancy and in the treatment of threatened abortion].
    Bengtsson LP
    Rev Fr Gynecol Obstet; 1968 Mar; 63(3):73-81. PubMed ID: 5761334
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hormonal function indices of the fetoplacental system during partusisten therapy of premature labor].
    Kurdrina EA; Krut-kovskaia NP; Kiriushchenkov AP
    Akush Ginekol (Mosk); 1981 May; (5):13-6. PubMed ID: 7294297
    [No Abstract]   [Full Text] [Related]  

  • 49. [Valve of intradermal hormone tests in the diagnosis of causes of threatened abortion].
    Peshev LP
    Vopr Okhr Materin Det; 1975 Sep; 20(9):67-70. PubMed ID: 1224553
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diagnostic value of plasma progesterone in nonendocrine incipient abortions in the 1st trimester].
    Rachev E
    Akush Ginekol (Sofiia); 1983; 22(4):270-3. PubMed ID: 6670697
    [No Abstract]   [Full Text] [Related]  

  • 51. [General conclusions: management of threatened abortion in the first trimester].
    Magnin P
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3 Pt 2):683-5. PubMed ID: 701751
    [No Abstract]   [Full Text] [Related]  

  • 52. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester.
    Mezzesimi A; Florio P; Reis FM; D'Aniello G; Sabatini L; Razzi S; Fineschi D; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):164-8. PubMed ID: 17046145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Utrogestan and high risk pregnancy].
    Marinov B; Petkova S; Dukovski A; Georgiev G; Garnizov T; Manchev V; Kolarov G; Iunakova M
    Akush Ginekol (Sofiia); 2004; 43(5):22-4. PubMed ID: 15518280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in erythrocyte P50 and its effect on O2 transport in intravenous tocolysis with fenoterol (Partusisten)].
    Karl C; Pelzer I; Gauch W; Gersonde K; Liedtke B; Jung H
    Z Geburtshilfe Perinatol; 1985; 189(2):56-64. PubMed ID: 4013446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in estriol excretion in the urine and kidney function during Partusisten infusion].
    Paulin F; Csömör S
    Z Geburtshilfe Perinatol; 1982 Oct; 186(5):244-8. PubMed ID: 6891153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Placental lactogen content in women with habitual abortion].
    Tereshchenko LI
    Vopr Okhr Materin Det; 1980 Feb; 25(2):46-8. PubMed ID: 7368644
    [No Abstract]   [Full Text] [Related]  

  • 58. [Our experience in using brikanil tokolytic therapy].
    Grigorov S; Despodova Ts; Serdev V
    Akush Ginekol (Sofiia); 1983; 22(4):273-7. PubMed ID: 6670698
    [No Abstract]   [Full Text] [Related]  

  • 59. Ultrasound and estradiol plasma levels in threatened abortion.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Battistelli P; Boldrini A
    Acta Eur Fertil; 1984; 15(4):287-94. PubMed ID: 6395604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of turinal and progesterone combined with chorionic gonadotropin on cellular immunity during the treatment of threatened abortion in the first and second trimesters].
    Zhuchenko PG; Lisovskaia TV; Gordiĭchuk VD
    Akush Ginekol (Mosk); 1988 Dec; (12):24-7. PubMed ID: 3266544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.